Latha Velayudhan

June 6, 2025

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer’s dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

Abstract Background: Alzheimer’s Disease (ad) patients often experience clinically significant agitation, leading to distress, increased healthcare costs and earlier institutionalisation.…

November 27, 2024

Adverse events caused by cannabinoids in middle aged and older adults for all indications: a meta-analysis of incidence rate difference

Abstract Background: Cannabinoid-based medicines (CBMs) are being used widely in older people. However, information on the incidence of adverse events…

March 29, 2021

Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis

Abstract Background: Cannabinoid-based medicines (CBMs) are being used widely in the elderly. However, their safety and tolerability in older adults…

February 2, 2021

Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older

Abstract This systematic review and metaregression analysis estimates the association between the delta-9-tetrahydrocannabinol (THC) dose of cannabinoid-based medicines and neuropsychiatric…